Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
JMS CoTSE:7702 +1.32%62 PB Ratio is 0.27 as of Jul. 30, 2026, which is 39% below its 10-year median of 0.44. GuruFocus rates TSE:7702 with a GF Score™ of 62/100 and a GF Value™ of 円469.13 (Fairly Valued). The stock has 10 warning signs investors should review. Among 787 Medical Devices & Instruments companies, JMS Co ranks better than 97.46% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-07-30), JMS Co's share price is 円459.00. JMS Co's Book Value per Share for the quarter that ended in Mar. 2026 was 円1,701.11. Hence, JMS Co's PB Ratio of today is 0.27.
Good Sign:
JMS Co Ltd stock PB Ratio (=0.27) is close to 10-year low of 0.25.
The historical rank and industry rank for JMS Co's PB Ratio or its related term are showing as below:
TSE:7702'
s PB Ratio Range Over the Past 10 Years
Min: 0.25 Med: 0.44 Max: 0.86
Current: 0.27
During the past 13 years, JMS Co's highest PB Ratio was 0.86. The lowest was 0.25. And the median was 0.44.
TSE:7702's PB Ratio is ranked better than 97.46% of 787
companies
in the Medical Devices & Instruments industry
Industry Median: 2.04
vs TSE:7702: 0.27
During the past 12 months, JMS Co's average Book Value Per Share Growth Rate was 2.10% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 2.60% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 3.60% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 3.60% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of JMS Co was 5.90% per year. The lowest was 0.00% per year. And the median was 2.75% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
JMS Co PB Ratio Related Terms
JMS Co PB Ratio Historical Data
* Premium members only.
The historical data trend for JMS Co's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, JMS Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
JMS Co PB Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, JMS Co's PB Ratio distribution charts can be found below:
* The bar in red indicates where JMS Co's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
JMS Co's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
JMS Co (TSE:7702) has a PB Ratio of 0.27 as of Jul. 30, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on JMS Co and its competitors. This is 39% below median its historical median of 0.44. Over the past decade, JMS Co's PB Ratio has ranged from 0.25 to 0.86. According to the industry distribution chart, JMS Co ranks #20 out of 787 companies in the Medical Devices & Instruments industry, placing it in the top 2.5%.
Is JMS Co's PB Ratio too high?
JMS Co's current PB Ratio of 0.27 is 39% below median its 10-year median of 0.44. Over the past 10 years, this metric has ranged from a low of 0.25 to a high of 0.86. The Medical Devices & Instruments industry median PB Ratio is 2.04. JMS Co's value of 0.27 is 86.8% below this industry median. Based on the distribution chart, JMS Co ranks #20 out of 787 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, JMS Co has a GF Score™ of 62/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does JMS Co's PB Ratio compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, JMS Co ranks #20 out of 787 companies for PB Ratio. This places JMS Co in the top 3% of its industry — outperforming the majority of peers. The industry median PB Ratio is 2.04. JMS Co's value of 0.27 is 86.8% below this benchmark. Historically, JMS Co's own PB Ratio has ranged from 0.25 to 0.86 over the past decade. While the company's 10-year median is 0.44 vs. the industry median of 2.04, JMS Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Devices & Instruments company?
The median PB Ratio among Medical Devices & Instruments companies is 2.04, based on 787 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. JMS Co's current PB Ratio of 0.27 is 86.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on JMS Co and its competitors. For the Medical Devices & Instruments industry, the median PB Ratio is 2.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. JMS Co's current PB Ratio is 0.27, which is 39% below median its own 10-year median of 0.44. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is JMS Co stock overvalued right now?
Based on GuruFocus' analysis, JMS Co (TSE:7702) is currently considered Fairly Valued. The stock's GF Value™ is 円469.13, compared to a current price of 円459.00 — trading 2.2% below its estimated fair value. The current PB Ratio is 0.27, which is 39% below median its 10-year median of 0.44 and 86.8% below the Medical Devices & Instruments industry median of 2.04. JMS Co's overall GF Score™ is 62/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For JMS Co (TSE:7702), the current PB Ratio is 0.27 as of Jul. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is JMS Co (TSE:7702) Overvalued in 2026?
Based on GuruFocus' analysis, JMS Co stock appears to be undervalued.
The current stock price of 円459.00 is trading 2.2% below its estimated GF Value™ of 円469.13.
GuruFocus considers JMS Co to be Fairly Valued.
Key valuation signals for TSE:7702:
PB Ratio: 0.27 (39% below median its 10-year median of 0.44)
GF Value™: 円469.13 vs. price of 円459.00 (2.2% below fair value)
Industry Position: 86.8% below the Medical Devices & Instruments median (#20 of 787)
No single metric tells the full story. See the TSE:7702 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
JMS Co Ltd is a Japan-based medical equipment manufacturer. The company is engaged in the manufacture, sale, export, and import of medical equipment and pharmaceuticals. Products offered by the company include an infusion pump, syringe pump, surgical gown, peritoneal dialysate, dialyzer, mask cap, sheet for treatment, pacemaker, heat exchanger, blood bag, among others. JMS has network operations in various countries including Europe, North America, Asia, the Middle East, Latin America and Africa.
62GF Score
Get the complete analysis for TSE:7702
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:7702 has been successfully added to your 
